Bulimia Nervosa Clinical Trial
— FAKTOfficial title:
Treatment of Eating Disorders - a Randomised, Controlled, Prospective Study
Verified date | March 2019 |
Source | Norwegian School of Sport Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
"Eating disorders" includes anorexia nervosa, bulimia nervosa, binge eating and other
specified feeding or eating disorder (OSFED). Common to all is the intensively occupation to
control food intake, body image and body weight. Most people with this kind of disorder don't
reach for professional help, or there may be more than 4 years before they do. Cognitive
behavior therapy is the foremost method of treatment of eating disorders, but up to 30-50% of
the patients don't respond to this. The investigators find it important to identify science
based alternatives of therapy, as this may reduce the health concern, and broaden the choice
of therapy methods. A former study by Sundgot-Borgen et al in 2002, found guided physical
activity to reduce symptoms of bulimia nervosa just as good as the traditional cognitive
therapy.
The primary objective of the project is to see whether the combination of physical exercise
and dietary therapy is more effective in treating eating disorders, than cognitive therapy.
Secondly, the investigators want to see whether there are any differences with regard to the
individual satisfaction of treatment method, and to associated costs. Interviews with a
sufficient number of participants from the PED-t arm to meet data saturation criteria, and
all theraphists in the new treatment offer, will give uniqe insight to experiences with the
treatment method and the delivery of treatment.
Status | Completed |
Enrollment | 128 |
Est. completion date | January 31, 2019 |
Est. primary completion date | January 31, 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Women, - BMI 17,5-35, - Age of 18-40 years, - DSM-5 criteria of bulimia nervosa, - DSM-5 criteria of Binge eating disorder - Living nearby Norwegian School of Sports Sciences, NSSS, in Oslo (Norway) Exclusion Criteria: - Age <18 and >40 years - BMI <17,5 and >35 - Pregnancy - Competing/experienced athlete - Anorexia nervosa - Currently, or during the past 2 years, in active treatment with cognitive therapy - Other personality disturbances - Suicidality |
Country | Name | City | State |
---|---|---|---|
Norway | Norwegian School of Sports Sciences | Oslo |
Lead Sponsor | Collaborator |
---|---|
Norwegian School of Sport Sciences | The Norwegian Women´s Public Health Association, University of Tromso |
Norway,
Sundgot-Borgen J, Rosenvinge JH, Bahr R, Schneider LS. The effect of exercise, cognitive therapy, and nutritional counseling in treating bulimia nervosa. Med Sci Sports Exerc. 2002 Feb;34(2):190-5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in muscular strength | Status of 1 repetition maximum, 1RM, muscular strength in squats, bench press and seated row | Pretest (week 0), post-test (week 17) and at 6, 12 and 24 months after treatment | |
Other | Change in cardiovascular endurance | CPET: with the use of modified Balke Treadmill performance evaluation test, The Borg scale (Borg, 1982) | Pre-test in week 0, Post-tests ( week 17), and at 6, 12 and 24 months after intervention. | |
Other | Change in bone mineral density | DXA (Dual-energy X-ray absorptiometry) | Pre-test in week 0, Post-test (week 17) and 6, 12, and 24 months post-treatment | |
Other | Change in body weight and bodycomposition | DXA (dual-energy x-ray absorptiometry) (weekly weight registration will also be kept in each arm of treatment) | Pre-test and post-test (week 17) and at 6,12,18 and 24 months post-treatment | |
Other | Change in nutritional status | Blood test to identify nutritional status of iron, folate, cholesterol and triglycerides, ApoA, ApoB and vitamin-D, folic acid | Pre-test, in week 8 of treatment, post-test (week 17) and at 6,12,18 and 24 months post-treatment | |
Other | Change in hormonal status | Blood test to evaluate hormonal status of estradiol, progesterone, CTX, P1nP, insulin, leptin, TSH, T3, T4, FSH, LH, cortisol | Pre-test, week 8 of treatment, post-test (week 17) and at 6,12,18 and 24 months post-treatment | |
Other | Change in dietary and nutritional intake | 24 hour recall interview: interview on the intake of food and beverage during the past 24 hours. | Pre-test, each 3rd week in treatment (a total of 5 interviews), post-test (week 17), and post-treatment (6,12, and 24 months post-treatment) | |
Other | Change in physical activity level | Wearing a GT3X-BT actigraph accelerometer for 7 consecutive days and making notes on daily activity in 30 minutes intervals | Pre-test in week 0, Post-test (week 17) and 6, 12, and 24 months post-treatment | |
Other | Interview: measure and explore patients experienced treatment satisfaction and outcome/benefits with PED-t. | Qualitative approaches, such as in-depth interviews, will give additional insights into ED-patients' perspectives, notably experiences and satisfaction with the treatment. A sufficient number of participants to meet data saturation criteria are qualitatively interviewed. Data are analyzed in four steps within the framework of systematic text condensation (Malterud 2012). |
Post treatment | |
Other | Interview: What are the theraphists experiences of their contribution to the PED-t program | Qualitative approaches, such as in-depth interviews, will give additional insights into the therapists' perspectives and experiences on delivering a new treatment offer for eating disorder. Data are analyzed in four steps within the framework of systematic text condensation (Malterud 2012). |
Post treatment | |
Other | Interview: What are the experiences of the participants who drop out of the PED-t program? | Data are analyzed in four steps within the framework of systematic text condensation (Malterud 2012). | Post treatment | |
Primary | Effectiveness of treatment, evaluated through the change in symptoms of eating disorder | Change in ED-symptoms are evaluated through screening and surveys: EDE-questionaire (Episodes of binge eating, episodes of purging, concern for body weight and appearance)(Fairburn, 2008), Clinical Impairment Assessment (CIA) (Fairburn, 2008), Eating Disorder Inventory-3 (EDI) (Garner, 2004), Eating Disturbance Scale (EDS-5) (Rosenvinge et al., 2000), DSM-5 (APA, 2013) | Pre-test in week 0, Post-tests (week 17), and at 6, 12, and 24 months after intervention. | |
Secondary | Expectations of treatment method for eating disorders | Interview on the expectations the patients have to the specified treatment method of eating disorders (arm of intervention) EPDEX (Clinton 2001) | Pre-test | |
Secondary | Experiences of the treatment method for eating disorders | Interview on the experiences the patients have to the specified treatment method of eating disorders (arm of intervention), EPDEX (Clinton 2001) | Post-test (week 17) | |
Secondary | Associated cost with treatment method | Calculation of the directly and indirectly cost related to treatment method | Pre-test | |
Secondary | Associated cost with treatment method | Calculation of the directly and indirectly cost related to treatment method | Post-test (week 17) | |
Secondary | Associated cost With treatment method | Calculation of the directly and indirectly cost related to treatment method | Post-test (by 6th month post-treatment) | |
Secondary | Associated cost With treatment method | Calculation of the directly and indirectly cost related to treatment method | Post-test (by 12th month post-treatment) | |
Secondary | Associated cost with treatment method | Calculation of the directly and indirectly cost related to treatment method | Post-test (by 24th month post-treatment) | |
Secondary | Global measurement of general psychopathology | Beck's Anxiety Inventory (BAI), Beck Depression Inventory (BDI), QoL (Diener), Utrecht Coping List, Resilience Scale for Adults, the outcome rating scale (ORS), the three-factor eating questionnaire (TFEQ), Binge eating Scale (BES), Cantril's Ladder, Exercise dependency test, compulsice exercise test | Pre-treatment | |
Secondary | Global measurement of general psychopathology | Beck's Anxiety Inventory (BAI), Beck Depression Inventory (BDI), QoL (Diener), Utrecht Coping List, Resilience Scale for Adults, the outcome rating scale (ORS), the three-factor eating questionnaire (TFEQ), Binge eating Scale (BES), Cantril's Ladder, Exercise dependency test, compulsice exercise test | Post-treatment (week 17) | |
Secondary | Global measurement of general psychopathology | Beck's Anxiety Inventory (BAI), Beck Depression Inventory (BDI), QoL (Diener), Utrecht Coping List, Resilience Scale for Adults, the outcome rating scale (ORS), the three-factor eating questionnaire (TFEQ), Binge eating Scale (BES), Cantril's Ladder, Exercise dependency test, compulsice exercise test | Post-treatment (by the 6th month post-treatment) | |
Secondary | Global measurement of general psychopathology | Beck's Anxiety Inventory (BAI), Beck Depression Inventory (BDI), QoL (Diener), Utrecht Coping List, Resilience Scale for Adults, the outcome rating scale (ORS), the three-factor eating questionnaire (TFEQ), Binge eating Scale (BES), Cantril's Ladder, Exercise dependency test, compulsice exercise test | Post-test (by 12th month post-treatment) | |
Secondary | Global measurement of general psychopathology | Beck's Anxiety Inventory (BAI), Beck Depression Inventory (BDI), QoL (Diener), Utrecht Coping List, Resilience Scale for Adults, the outcome rating scale (ORS), the three-factor eating questionnaire (TFEQ), Binge eating Scale (BES), Cantril's Ladder, Exercise dependency test, compulsice exercise test | Post-test (by 24th month post-treatment) | |
Secondary | Group climate | coerciveness scale from Therapeutic Factor Inventory (Lese & MacNair-Semands, 2000). | week 1-16 | |
Secondary | Working AIliance | Working AIliance Inventory (Horwath & Greenberg, 1989) | week 1-16 | |
Secondary | Experiences of the treatment method for eating disorders | Interview on the experiences the patients have to the specified treatment method of eating disorders (arm of intervention) (Clinton 2001) | Post-test (6 months) | |
Secondary | Experiences of the treatment method for eating disorders | Interview on the experiences the patients have to the specified treatment method of eating disorders (arm of intervention) (Clinton 2001) | Post-test (by 12th month post-treatment) | |
Secondary | Experiences of the treatment method for eating disorders | Interview on the experiences the patients have to the specified treatment method of eating disorders (arm of intervention) (Clinton 2001) | Post-test (by 24th month post-treatment) | |
Secondary | Change in eating disorder behavior and cognitions related to body figure and bodyweight | Evaluation after each therapy session on progress in reducing eating disordered behaviour (binging and purging) and on changes of cognitions on body figure and -weight | Week 1-16 during treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04174703 -
Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing
|
N/A | |
Terminated |
NCT04278755 -
Binge Eating & Birth Control
|
Phase 2 | |
Withdrawn |
NCT02978742 -
Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder
|
N/A | |
Withdrawn |
NCT00988481 -
Topiramate Augmentation in Bulimia Nervosa Partial Responders
|
Phase 4 | |
Completed |
NCT00184301 -
A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder.
|
N/A | |
Completed |
NCT00522769 -
Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents
|
Phase 1/Phase 2 | |
Completed |
NCT00304187 -
Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
|
Phase 2 | |
Recruiting |
NCT04409457 -
Self-Control in Bulimia Nervosa
|
N/A | |
Recruiting |
NCT05509257 -
Naltrexone Neuroimaging in Teens With Eating Disorders
|
Early Phase 1 | |
Recruiting |
NCT05862389 -
Study on the Mechanism of Eating Disorder
|
||
Recruiting |
NCT05937243 -
Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating
|
N/A | |
Recruiting |
NCT05728021 -
Smartphone-based Aftercare for Inpatients With Bulimia Nervosa
|
N/A | |
Completed |
NCT03781921 -
The Neural Bases of Emotion Regulation in Bulimia Nervosa
|
||
Completed |
NCT02553824 -
FDA Approved Medication to Reduce Binge Eating and/or Purging
|
Phase 1 | |
Terminated |
NCT04041024 -
Decision-making and Risk-taking in Bulimia
|
N/A | |
Completed |
NCT04265131 -
Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome?
|
N/A | |
Recruiting |
NCT06431854 -
Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program
|
N/A | |
Recruiting |
NCT02960152 -
Periodontal Impact of Eating Disorders (the PERIOED Study)
|
N/A | |
Completed |
NCT00916071 -
Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders
|
N/A | |
Terminated |
NCT00308776 -
Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
|
N/A |